Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy
- PMID: 18755602
- PMCID: PMC2747287
- DOI: 10.1016/j.jvir.2008.06.008
Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy
Abstract
Purpose: To test whether different-sized iron oxide-containing Embosphere (IOE) particles can be detected by dedicated magnetic resonance (MR) imaging when injected intraarterially in an animal model of liver cancer and whether their distribution could be accurately predicted by MR imaging before confirmation with histopathologic analysis.
Materials and methods: Twenty New Zealand White rabbits implanted with VX2 liver tumor were randomly assigned to undergo embolization with 100-300-microm particles (group S; n = 10) or 300-500-microm particles (group L; n = 10). Embolization was performed with the catheter placed in the proper hepatic artery. T2*-weighted multiplanar MR imaging was performed within 24 hours after the procedure to detect paramagnetic IOE susceptibility artifact. MR imaging interpretation parameters included presence of artifact in the artery and/or at the tumor bed. Hematoxylin and eosin- and Prussian blue-stained pathologic slides were also obtained and the presence of IOE was evaluated similarly.
Results: The MR detectability rates for IOEs were 100% in both groups. Paramagnetic susceptibility IOE artifact inside the tumor was detected in 30% of group S animals. On pathologic analysis, IOE particles were detected inside the tumor in 70% of this group. IOEs in group L were found outside the tumor within the hepatic artery on MR imaging and histopathologic study (P < .05).
Conclusions: MR imaging readily detected IOE particles in an animal model of liver cancer regardless of the particle size. The smaller particles (100-300 microm) were delivered inside the tumor or in close proximity to the tumor margin, justifying their use for drug delivery or precise embolization.
Conflict of interest statement
None of the other authors have identified a conflict of interest.
Figures
Similar articles
-
Iron-Oxide Nanocluster Labeling of Clostridium novyi-NT Spores for MR Imaging-Monitored Locoregional Delivery to Liver Tumors in Rat and Rabbit Models.J Vasc Interv Radiol. 2019 Jul;30(7):1106-1115.e1. doi: 10.1016/j.jvir.2018.11.002. Epub 2019 Apr 2. J Vasc Interv Radiol. 2019. PMID: 30952520
-
MR imaging detection of superparamagnetic iron oxide loaded tris-acryl embolization microspheres.J Vasc Interv Radiol. 2007 Oct;18(10):1287-95. doi: 10.1016/j.jvir.2007.07.015. J Vasc Interv Radiol. 2007. PMID: 17911520
-
Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors.J Vasc Interv Radiol. 2008 Oct;19(10):1483-9. doi: 10.1016/j.jvir.2008.06.017. J Vasc Interv Radiol. 2008. PMID: 18922400 Free PMC article.
-
Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.Eur Radiol. 2001;11(11):2319-31. doi: 10.1007/s003300100908. Eur Radiol. 2001. PMID: 11702180 Review.
-
Magnetic resonance imaging and expression of vascular endothelial growth factor in hepatocellular nodules in cirrhosis and hepatocellular carcinomas.Top Magn Reson Imaging. 2005 Feb;16(1):67-75. doi: 10.1097/01.rmr.0000191133.91603.d2. Top Magn Reson Imaging. 2005. PMID: 16314697 Review.
Cited by
-
Hepatic fibrosis and short-term clinical efficacy after hepatic artery embolization for unresectable hepatocellular carcinoma using doxorubicin-eluting HepaSphere.Transl Cancer Res. 2020 Mar;9(3):1361-1370. doi: 10.21037/tcr.2020.01.15. Transl Cancer Res. 2020. PMID: 35117484 Free PMC article.
-
A Novel Inherently Radiopaque Bead for Transarterial Embolization to Treat Liver Cancer - A Pre-clinical Study.Theranostics. 2016 Jan 1;6(1):28-39. doi: 10.7150/thno.13137. eCollection 2016. Theranostics. 2016. PMID: 26722371 Free PMC article.
-
Rabbit VX2 Liver Tumor Model: A Review of Clinical, Biology, Histology, and Tumor Microenvironment Characteristics.Front Oncol. 2022 May 10;12:871829. doi: 10.3389/fonc.2022.871829. eCollection 2022. Front Oncol. 2022. PMID: 35619923 Free PMC article. Review.
-
Regional Chemotherapy for Biliary Tract Tumors and Hepatocellular Carcinoma.Surg Oncol Clin N Am. 2019 Oct;28(4):717-729. doi: 10.1016/j.soc.2019.06.008. Epub 2019 Aug 7. Surg Oncol Clin N Am. 2019. PMID: 31472915 Free PMC article. Review.
-
CIRSE Standards of Practice on Hepatic Transarterial Chemoembolisation.Cardiovasc Intervent Radiol. 2021 Dec;44(12):1851-1867. doi: 10.1007/s00270-021-02968-1. Epub 2021 Oct 25. Cardiovasc Intervent Radiol. 2021. PMID: 34694454
References
-
- Lau WY, Ho S, Leung TWT, et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys. 1998;40:583–592. - PubMed
-
- Stuart K. Chemoembolization in the management of liver tumors. Oncologist. 2003;8:425–437. - PubMed
-
- Liapi E, Geschwind JFH. Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol. 2007;25:978–986. - PubMed
-
- Maluccio M, Covey AM, Gandhi R, et al. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm. J Vasc Interv Radiol. 2005;16:955–961. - PubMed
-
- Okada H, Toguchi H. Biodegradable microspheres in drug-delivery. Crit Rev Ther Drug Carrier Syst. 1995;12:1–99. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical